Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
UREA C 13
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
UREA C 13
×
Maximum Phase:
4
First Approval:
1996
UNII:
W6KX9E6D8X
Molecule Type:
Small molecule
Molecular Formula:
CH4N2O
Molecular Weight:
61.05
AlogP:
-0.98
PSA:
69.11
HBD:
2.0
HBA:
#RotB:
0.0
Source:
PHENYLBUTANOIC ACID
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
PHENYLBUTANOIC ACID
×
Maximum Phase:
4
First Approval:
1996
UNII:
7WY7YBI87E
Molecule Type:
Small molecule
Molecular Formula:
C10H12O2
Molecular Weight:
164.2
AlogP:
2.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AZELASTINE HYDROCHLORIDE
(1996)
Small molecule
Histamine H1 receptor antagonist
NASAL; OPHTHALMIC
Approved
Conjunctivitis, Allergic; Nasal Obstruction; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinitis, Vasomotor
AZELASTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
0L591QR10I
Molecule Type:
Small molecule
Molecular Formula:
C22H25Cl2N3O
Molecular Weight:
418.37
AlogP:
4.3
PSA:
38.13
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SPARFLOXACIN
(1996)
Small molecule
Bacterial DNA gyrase inhibitor
ORAL
Approved
Bacterial Infections
SPARFLOXACIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
Q90AGA787L
Molecule Type:
Small molecule
Molecular Formula:
C19H22F2N4O3
Molecular Weight:
392.41
AlogP:
2.08
PSA:
100.59
HBD:
3.0
HBA:
#RotB:
3.0
Source:
FOSFOMYCIN TROMETHAMINE
(1996)
Small molecule
UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
ORAL
Approved
Urinary Tract Infections
FOSFOMYCIN TROMETHAMINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
7FXW6U30GY
Molecule Type:
Small molecule
Molecular Formula:
C7H18NO7P
Molecular Weight:
259.19
AlogP:
-0.09
PSA:
70.06
HBD:
2.0
HBA:
#RotB:
1.0
Source:
REMIFENTANIL HYDROCHLORIDE
(1996)
Small molecule
Mu opioid receptor agonist
Unknown
Approved
Unknown
REMIFENTANIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
5V444H5WIC
Molecule Type:
Small molecule
Molecular Formula:
C20H29ClN2O5
Molecular Weight:
412.91
AlogP:
2.0
PSA:
76.15
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ROPIVACAINE HYDROCHLORIDE
(1996)
Small molecule
Sodium channel alpha subunit blocker
INJECTION
Approved
Acute Pain
ROPIVACAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
35504LBE2T
Molecule Type:
Small molecule
Molecular Formula:
C17H27ClN2O
Molecular Weight:
310.87
AlogP:
3.51
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LEVOFLOXACIN
(1996)
Small molecule
DNA gyrase inhibitor
INJECTION; OPHTHALMIC; ORAL
Approved
Acne Vulgaris; Bacterial Infections; Bronchitis, Chronic; Conjunctivitis, Bacterial; Corneal Ulcer; Eye Infections; Infections; Otitis Externa; Pneumonia; Sinusitis; Urinary Tract Infections
LEVOFLOXACIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
RIX4E89Y14
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN3O4
Molecular Weight:
361.37
AlogP:
1.54
PSA:
75.01
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SIMETHICONE
(1996)
Small molecule
Antifoaming agent
Unknown
Approved
Unknown
SIMETHICONE
×
Maximum Phase:
4
First Approval:
1996
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PENTOSAN POLYSULFATE SODIUM
(1996)
Small molecule
Unknown
ORAL
Approved
Unknown
PENTOSAN POLYSULFATE SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
914032762Y
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DONEPEZIL
(1996)
Small molecule
Unknown
Unknown
Approved
Dementia
DONEPEZIL
×
Maximum Phase:
4
First Approval:
1996
UNII:
8SSC91326P
Molecule Type:
Small molecule
Molecular Formula:
C24H29NO3
Molecular Weight:
379.5
AlogP:
4.36
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
TOPOTECAN HYDROCHLORIDE
(1996)
Small molecule
DNA topoisomerase I, mitochondrial inhibitor
INJECTION; INTRAVENOUS; ORAL
Approved
Carcinoma; Carcinoma, Ovarian Epithelial; Carcinoma, Small Cell; Ovarian Neoplasms; Small Cell Lung Carcinoma
TOPOTECAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
956S425ZCY
Molecule Type:
Small molecule
Molecular Formula:
C23H24ClN3O5
Molecular Weight:
457.91
AlogP:
1.85
PSA:
104.89
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VALSARTAN
(1996)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Cardiovascular Diseases; Diabetes Mellitus; Heart Failure; Hypertension; Myocardial Infarction; Stroke; Ventricular Dysfunction, Left
VALSARTAN
×
Maximum Phase:
4
First Approval:
1996
UNII:
80M03YXJ7I
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O3
Molecular Weight:
435.53
AlogP:
4.16
PSA:
112.07
HBD:
2.0
HBA:
#RotB:
10.0
Source:
CABERGOLINE
(1996)
Small molecule
Dopamine D2 receptor agonist
ORAL
Approved
Parkinson Disease; Pituitary Neoplasms
CABERGOLINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
LL60K9J05T
Molecule Type:
Small molecule
Molecular Formula:
C26H37N5O2
Molecular Weight:
451.62
AlogP:
3.19
PSA:
71.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
BUTENAFINE
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
BUTENAFINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
91Y494NL0X
Molecule Type:
Small molecule
Molecular Formula:
C23H27N
Molecular Weight:
317.48
AlogP:
5.77
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FEXOFENADINE HYDROCHLORIDE
(1996)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Hypersensitivity; Rhinitis, Allergic, Seasonal; Urticaria
FEXOFENADINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
2S068B75ZU
Molecule Type:
Small molecule
Molecular Formula:
C32H40ClNO4
Molecular Weight:
538.13
AlogP:
5.51
PSA:
81.0
HBD:
3.0
HBA:
#RotB:
10.0
Source:
AMLEXANOX
(1996)
Small molecule
Phosphodiesterase 4 inhibitor
DENTAL; TOPICAL
Approved
Lung Diseases, Obstructive
AMLEXANOX
×
Maximum Phase:
4
First Approval:
1996
UNII:
BRL1C2459K
Molecule Type:
Small molecule
Molecular Formula:
C16H14N2O4
Molecular Weight:
298.3
AlogP:
2.75
PSA:
106.42
HBD:
2.0
HBA:
#RotB:
2.0
Source:
TIZANIDINE
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
TIZANIDINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
6AI06C00GW
Molecule Type:
Small molecule
Molecular Formula:
C9H8ClN5S
Molecular Weight:
253.72
AlogP:
1.72
PSA:
62.2
HBD:
2.0
HBA:
#RotB:
1.0
Source:
MIDODRINE
(1996)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
MIDODRINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
6YE7PBM15H
Molecule Type:
Small molecule
Molecular Formula:
C12H18N2O4
Molecular Weight:
254.29
AlogP:
-0.19
PSA:
93.81
HBD:
3.0
HBA:
#RotB:
6.0
Source:
BRIMONIDINE TARTRATE
(1996)
Small molecule
Adrenergic receptor alpha-2 agonist
OPHTHALMIC; TOPICAL
Approved
Erythema; Glaucoma; Glaucoma, Open-Angle; Hypertension; Intraocular Pressure; Ocular Hypertension; Rosacea
BRIMONIDINE TARTRATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
4S9CL2DY2H
Molecule Type:
Small molecule
Molecular Formula:
C15H16BrN5O6
Molecular Weight:
442.23
AlogP:
1.76
PSA:
62.2
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TIZANIDINE HYDROCHLORIDE
(1996)
Small molecule
Adrenergic receptor alpha-2 agonist
ORAL
Approved
Muscle Spasticity
TIZANIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
B53E3NMY5C
Molecule Type:
Small molecule
Molecular Formula:
C9H9Cl2N5S
Molecular Weight:
290.18
AlogP:
1.72
PSA:
62.2
HBD:
2.0
HBA:
#RotB:
1.0
Source:
DONEPEZIL HYDROCHLORIDE
(1996)
Small molecule
Acetylcholinesterase inhibitor
ORAL
Approved
Alzheimer Disease; Dementia
DONEPEZIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
3O2T2PJ89D
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClNO3
Molecular Weight:
415.96
AlogP:
4.36
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
FOSPHENYTOIN SODIUM
(1996)
Small molecule
Sodium channel alpha subunit blocker
INJECTION
Approved
Seizures
FOSPHENYTOIN SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
7VLR55452Z
Molecule Type:
Small molecule
Molecular Formula:
C16H13N2Na2O6P
Molecular Weight:
406.24
AlogP:
1.55
PSA:
116.17
HBD:
3.0
HBA:
#RotB:
5.0
Source:
IRINOTECAN HYDROCHLORIDE
(1996)
Small molecule
DNA topoisomerase I inhibitor
INJECTION; INTRAVENOUS
Approved
Adenocarcinoma; Carcinoma
IRINOTECAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
042LAQ1IIS
Molecule Type:
Small molecule
Molecular Formula:
C33H45ClN4O9
Molecular Weight:
677.19
AlogP:
4.09
PSA:
114.2
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DILTIAZEM MALATE
(1996)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Unknown
DILTIAZEM MALATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
14Y6444DRP
Molecule Type:
Small molecule
Molecular Formula:
C26H32N2O9S
Molecular Weight:
548.61
AlogP:
3.37
PSA:
59.08
HBD:
0.0
HBA:
#RotB:
6.0
Source:
AZELASTINE
(1996)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Hypersensitivity; Nasal Obstruction
AZELASTINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
ZQI909440X
Molecule Type:
Small molecule
Molecular Formula:
C22H24ClN3O
Molecular Weight:
381.91
AlogP:
4.3
PSA:
38.13
HBD:
0.0
HBA:
#RotB:
3.0
Source:
NILUTAMIDE
(1996)
Small molecule
Androgen Receptor antagonist
ORAL
Approved
Neoplasms; Prostatic Neoplasms
NILUTAMIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
51G6I8B902
Molecule Type:
Small molecule
Molecular Formula:
C12H10F3N3O4
Molecular Weight:
317.22
AlogP:
2.45
PSA:
92.55
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SODIUM PHENYLBUTYRATE
(1996)
Small molecule
Glutamine sequestering agent
Unknown
Approved
Hyperammonemia; Urea Cycle Disorders, Inborn
SODIUM PHENYLBUTYRATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
NT6K61736T
Molecule Type:
Small molecule
Molecular Formula:
C10H11NaO2
Molecular Weight:
186.19
AlogP:
2.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ATORVASTATIN
(1996)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases; Coronary Artery Disease; Hypercholesterolemia
ATORVASTATIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
A0JWA85V8F
Molecule Type:
Small molecule
Molecular Formula:
C33H35FN2O5
Molecular Weight:
558.65
AlogP:
6.31
PSA:
111.79
HBD:
4.0
HBA:
#RotB:
12.0
Source:
BUTENAFINE HYDROCHLORIDE
(1996)
Small molecule
Squalene monooxygenase inhibitor
TOPICAL
Approved
Tinea
BUTENAFINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
R8XA2029ZI
Molecule Type:
Small molecule
Molecular Formula:
C23H28ClN
Molecular Weight:
353.94
AlogP:
5.77
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ETOPOSIDE PHOSPHATE
(1996)
Small molecule
DNA topoisomerase II alpha inhibitor
INJECTION
Approved
Carcinoma, Small Cell; Lung Neoplasms; Neoplasms; Small Cell Lung Carcinoma
ETOPOSIDE PHOSPHATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
528XYJ8L1N
Molecule Type:
Small molecule
Molecular Formula:
C29H33O16P
Molecular Weight:
668.54
AlogP:
1.1
PSA:
207.36
HBD:
4.0
HBA:
#RotB:
7.0
Source:
GEMCITABINE HYDROCHLORIDE
(1996)
Small molecule
DNA polymerase (alpha/delta/epsilon) inhibitor
INJECTION; INTRAVENOUS
Approved
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Pancreatic Neoplasms
GEMCITABINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
U347PV74IL
Molecule Type:
Small molecule
Molecular Formula:
C9H12ClF2N3O4
Molecular Weight:
299.66
AlogP:
-1.29
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
BETAINE
(1996)
Small molecule
Betaine-homocysteine S-methyltransferase substrate
ORAL
Approved
Depressive Disorder; Homocystinuria
BETAINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
3SCV180C9W
Molecule Type:
Small molecule
Molecular Formula:
C5H12NO2+
Molecular Weight:
118.16
AlogP:
-0.22
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
RITONAVIR
(1996)
Small molecule
Cytochrome P450 3A inhibitor
ORAL
Approved
HIV Infections; Hepatitis C; Hepatitis C, Chronic; Virus Diseases
RITONAVIR
×
Maximum Phase:
4
First Approval:
1996
UNII:
O3J8G9O825
Molecule Type:
Small molecule
Molecular Formula:
C37H48N6O5S2
Molecular Weight:
720.96
AlogP:
5.91
PSA:
145.78
HBD:
4.0
HBA:
#RotB:
17.0
Source:
ZILEUTON
(1996)
Small molecule
Arachidonate 5-lipoxygenase inhibitor
ORAL
Approved
Asthma
ZILEUTON
×
Maximum Phase:
4
First Approval:
1996
UNII:
V1L22WVE2S
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O2S
Molecular Weight:
236.3
AlogP:
2.73
PSA:
66.56
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IRINOTECAN
(1996)
Small molecule
Unknown
Unknown
Approved
Neoplasms
IRINOTECAN
×
Maximum Phase:
4
First Approval:
1996
UNII:
7673326042
Molecule Type:
Small molecule
Molecular Formula:
C33H38N4O6
Molecular Weight:
586.69
AlogP:
4.09
PSA:
114.2
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
44
45
46
47
48
49
50
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA